Heltra: Explore Life – Discover More – Live Better

FDA accepts SpringWorks' application for mirdametinib for NF1-PN


FDA accepts SpringWorks’ application for mirdametinib for NF1-PN

Source: Seekingalpha

ADVERTISEMENT